These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7069702)

  • 1. Synthesis and peripheral cardiovascular action of cis- and trans-2-(3,4-dimethoxybenzyl)cyclopentylamine hydrochlorides.
    Teller SR; Jarboe CH
    J Med Chem; 1982 Mar; 25(3):227-31. PubMed ID: 7069702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,5-Bis(3,4-dimethoxybenzyl)cyclopentylamine, a peripheral dopamine blocking agent.
    Jarboe CH; Lipson SF; Bannon MJ; Dunnigan DA
    J Med Chem; 1978 Dec; 21(12):1318-20. PubMed ID: 569208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the depressor response to dopamine in the rat treated with phenoxybenzamine.
    Chevillard C; Mathieu MN
    Eur J Pharmacol; 1979 Jul; 56(4):371-8. PubMed ID: 477731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analogues of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides.
    Erhardt PW; Gorczynski RJ; Anderson WG
    J Med Chem; 1979 Aug; 22(8):907-11. PubMed ID: 40027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral vascular response to phenoxybenzamine infusion in isolated dog hindlimb.
    Diana JN; Masden RR
    Am J Physiol; 1966 Mar; 210(3):545-52. PubMed ID: 5933206
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of bulbocapnine as a peripheral dopamine receptor antagonists in the anesthetized cat.
    Pendleton RG; Finlay E; Sherman S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(2):171-8. PubMed ID: 241025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possibe mechanisms involved in the depressor response to dopamine.
    Morishita H; Furukawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):317-27. PubMed ID: 4447412
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gastrin, histamine, serotonin, and adrenergic amines on gastroesophageal sphincter pressure in the dog.
    Strombeck DR; Harrold D
    Am J Vet Res; 1985 Aug; 46(8):1684-90. PubMed ID: 4037495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational requirements for dopamine-induced vasodilation.
    Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in antagonistic effect of morphine against depressor response to dopamine.
    Furukawa T; Kushiku K; Kawagoe T
    Jpn J Pharmacol; 1974 Aug; 24(4):635-8. PubMed ID: 4455972
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects.
    Contreras F; Fouillioux C; Lares M; Bolívar H; Hernández RH; Velasco M; Cano R; Chacin M; Bermúdez V
    Am J Ther; 2010; 17(3):320-4. PubMed ID: 20216207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
    Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
    Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological observations on the hypotensive action of extracts of teleost fish Urophyses (urotensin I) in the rat.
    Lederis K; Medaković M
    Br J Pharmacol; 1974 Jul; 51(3):315-24. PubMed ID: 4375526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system actions of 2,5-bis(3,4-dimethoxybenzyl) cyclopentyl amine, a peripheral dopamine blocking agent.
    Bannon MJ; Jarboe CH; Carr LA; Duncan GE
    Life Sci; 1980 Jan; 26(3):225-29. PubMed ID: 7360005
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of some newer piperazinoquinazolones as cardiovascular agents.
    Dubey M; Verma VK; Shanker K; Sinha JN; Bhargava KP; Kishor K
    Pharmazie; 1979 Jan; 34(1):18-20. PubMed ID: 432250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methysergide or phenoxybenzamine on the renal and cardiovascular responses to endotoxin in rats.
    Keeler R
    Circ Shock; 1981; 8(3):361-8. PubMed ID: 7249264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.